comprehensive -WSS

comprehensive

author：comprehensive 2025-09-29 21:23:34 - browse：3959

President Biden's White House announced the first 10 medicines that will be up first in its new drug price negotiation program. Anna Moneymaker/Getty Images

WASHINGTON — Medicare on Tuesday announced it will negotiate prices for 10 drugs, including major blood thinners and diabetes medications, in the first round of its negotiation program created in Democrats’ drug pricing reform law.

The drugs include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, Johnson & Johnson’s blood thinner Xarelto, Merck’s diabetes drug Januvia, AstraZeneca’s diabetes drug Farxiga, Novartis’ heart failure treatment Entresto, Amgen’s rheumatoid arthritis drug Enbrel, Johnson & Johnson and AbbVie’s blood cancer treatment Imbruvica, J&J’s anti-inflammatory medicine Stelara, and Novo Nordisk insulins that go by names including Fiasp and NovoLog.

The new prices will be announced on Sept. 1, 2024, and will go into effect on Jan. 1, 2026. The drugs were chosen from a list of 50 treatments that cost Medicare’s pharmacy drug benefit the most money. The selected medicines cost Medicare more than $50 billion and made up 20% of the Medicare program’s pharmacy drug costs over a one-year period, the Department of Health and Human Services said. (Read more here about the winners and losers of the selection.)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Wikipedia

WSS

Kansas bar where gunfire wounded 9 last month closes permanently

Cybersecurity threat forces Lurie Children's to take systems offline

'Brian's Song' at 50 still offers lessons about cancer for today

Vertigo drug brings hope for rare neuron disorder, Niemann

Paxlovid rebound happens. Why and to whom are still a mystery

Sweden knocks USA out of World Cup in penalty kicks

focus

comprehensive

entertainment

Hollywood unions extend contract negotiations for actors

It was time to plan for my old age. If only I could stop crying

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Quicker fix for pulse oximeters urged during FDA public meeting

Wildfire smoke exposes gaps in outdoor worker protections

Vertex non

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Google's generative AI to analyze medical images — and talk to docs

Jerome Adams on the need for new antivirals for Covid

Even great ERs can’t make up for American health disparities

hotspot

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Flash flood warnings continue for parts of Missouri, Illinois

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

NFL doctors' conflicts of interest could endanger players, report says

FDA drug safety: Singulair case shows systemic surveillance flaws

focus

Wikipedia

entertainment

Wikipedia